Researchers explore how AI-driven tumor-infiltrating lymphocyte (TIL) assessments outperform manual methods in precision but stress the need for robust datasets to ensure reliability in clinical ...
Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab The prognostic model demonstrated ...
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results